Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berthold Hocher

Showing results (11-20 of 324) with videos related to

Pageof 33
Sort By:
Nephron|February 10, 2017
Why Current PTH Assays Mislead Clinical Decision Making in Patients with Secondary HyperparathyroidismBerthold Hocher, Lianghong Yin
Nature Reviews. Nephrology|October 10, 2017
Diabetic nephropathy: Renoprotective effects of GLP1R agonists and SGLT2 inhibitorsBerthold Hocher, Oleg Tsuprykov
Clinical Chemistry and Laboratory Medicine|August 16, 2017
Need for better PTH assays for clinical research and patient treatmentBerthold Hocher, Shufei Zeng
Oncotarget|October 15, 2017
DPP4 inhibition prevents AKIChristoph Reichetzeder, Berthold Hocher
Kidney Diseases (Basel, Switzerland)|August 9, 2017
Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBDBerthold Hocher, Andreas Pasch
Kidney International|July 2, 2013
Vitamin D and cardiovascular risk in postmenopausal women: how to translate preclinical evidence into benefit for patientsBerthold Hocher, Christoph Reichetzeder
Human Reproduction Open|July 11, 2026
Beyond cardiovascular risk: is 'normal' blood pressure too high for reproductive success?Berthold Hocher, Shujuan Ma
Pediatric Transplantation|March 22, 2002
The emerging role of gene polymorphisms determining outcome after solid-organ transplantationGuido Filler, Berthold Hocher
Clinical Journal of the American Society of Nephrology : CJASN|March 7, 2018
Clear the Fog around Parathyroid Hormone Assays: What Do iPTH Assays Really Measure?Berthold Hocher, Shufei Zeng
Journal of Molecular Endocrinology|April 20, 2017
Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathyAhmed A Hasan, Berthold Hocher
Pageof 33

Showing results (11-20 of 324) with videos related to

Sort By:
Pageof 33
Nephron|February 10, 2017
Why Current PTH Assays Mislead Clinical Decision Making in Patients with Secondary HyperparathyroidismBerthold Hocher, Lianghong Yin
Nature Reviews. Nephrology|October 10, 2017
Diabetic nephropathy: Renoprotective effects of GLP1R agonists and SGLT2 inhibitorsBerthold Hocher, Oleg Tsuprykov
Clinical Chemistry and Laboratory Medicine|August 16, 2017
Need for better PTH assays for clinical research and patient treatmentBerthold Hocher, Shufei Zeng
Oncotarget|October 15, 2017
DPP4 inhibition prevents AKIChristoph Reichetzeder, Berthold Hocher
Kidney Diseases (Basel, Switzerland)|August 9, 2017
Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBDBerthold Hocher, Andreas Pasch
Kidney International|July 2, 2013
Vitamin D and cardiovascular risk in postmenopausal women: how to translate preclinical evidence into benefit for patientsBerthold Hocher, Christoph Reichetzeder
Human Reproduction Open|July 11, 2026
Beyond cardiovascular risk: is 'normal' blood pressure too high for reproductive success?Berthold Hocher, Shujuan Ma
Pediatric Transplantation|March 22, 2002
The emerging role of gene polymorphisms determining outcome after solid-organ transplantationGuido Filler, Berthold Hocher
Clinical Journal of the American Society of Nephrology : CJASN|March 7, 2018
Clear the Fog around Parathyroid Hormone Assays: What Do iPTH Assays Really Measure?Berthold Hocher, Shufei Zeng
Journal of Molecular Endocrinology|April 20, 2017
Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathyAhmed A Hasan, Berthold Hocher
Pageof 33